IGM BIOSCIENCES INC (IGMS) Stock Analyst Ratings
USA - NASDAQ:IGMS - US4495851085 - Common Stock
1.27 USD
-0.03 (-2.31%)
1.28 USD
+0.01 (+0.79%)
ChartMill assigns a Buy % Consensus number of 49% to IGMS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.27. This target is 0.39% above the current price.
IGMS was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about IGMS.
In the previous month the buy percentage consensus was at a similar level.
IGMS was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-11 | Truist Securities | Maintains | Hold -> Hold |
| 2025-01-13 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2025-01-10 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2025-01-10 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2025-01-10 | Stifel | Downgrade | Buy -> Hold |
| 2025-01-10 | Truist Securities | Maintains | Hold -> Hold |
| 2025-01-10 | Jefferies | Downgrade | Buy -> Hold |
| 2024-12-06 | BMO Capital | Initiate | Outperform |
| 2024-11-11 | Stifel | Maintains | Buy -> Buy |
| 2024-10-18 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-01 | Guggenheim | Maintains | Buy -> Buy |
| 2024-10-01 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-01 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-10-01 | Truist Securities | Downgrade | Buy -> Hold |
| 2024-10-01 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2024-09-05 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-08-23 | Truist Securities | Maintains | Buy -> Buy |
| 2024-08-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-15 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-08-15 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-05-09 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-18 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-03-12 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-03-08 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-02-09 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2023-12-15 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-12-07 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-12-06 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
IGM BIOSCIENCES INC / IGMS FAQ
What do analysts expect the price target to be for IGM BIOSCIENCES INC (IGMS)?
9 analysts have analysed IGMS and the average price target is 1.27 USD. This implies a price increase of 0.39% is expected in the next year compared to the current price of 1.27.
Can you provide the consensus rating for IGM BIOSCIENCES INC stock?
The consensus rating for IGM BIOSCIENCES INC (IGMS) is 48.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.